137 related articles for article (PubMed ID: 3720235)
1. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
Montemurro NE; Damiano M
Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
[No Abstract] [Full Text] [Related]
2. [Buflomedil chlorhydrate in the treatment of retinopathies].
Spallone A; Porta E; Bertazzi E; Ridling P; Ortolina S; Fatigati G; Carlevaro G; Visentin E; Capilli G
Clin Ter; 1987 Apr; 121(2):125-8. PubMed ID: 2956000
[No Abstract] [Full Text] [Related]
3. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
Coglitore S; Manganaro A; Barbera MC; Cento D; Buda D; Arrigo F; Consolo F
Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163
[No Abstract] [Full Text] [Related]
4. Our experience with the use of buflomedil chlorhydrate in a mixed population of vasculopathic patients.
Battaglia L; Valgiusti D; Di Paola FM
J Int Med Res; 1984; 12(2):63-72. PubMed ID: 6724128
[TBL] [Abstract][Full Text] [Related]
5. Dialysis clearance of buflomedil in hemodialysed patients.
Rey E; Moynot A; d'Athis P; Pello JY; Maurel A; Frydman MO; Buisson C; Olive G
Arzneimittelforschung; 1996 May; 46(5):492-5. PubMed ID: 8737633
[TBL] [Abstract][Full Text] [Related]
6. [Use of buflomedil chlorhydrate in vertiginous patients. Vertigo].
Pianura CM; Di Lillo ML; Galati F; Massatani M; Mignano M
Minerva Cardioangiol; 1985 Jun; 33(6):369-72. PubMed ID: 4047427
[No Abstract] [Full Text] [Related]
7. [Buflomedil chlorhydrate in peripheral vasculopathies].
Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S
Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055
[No Abstract] [Full Text] [Related]
8. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
Foray J; Baisse PE; Mont JP; Cahen C
Sem Hop; 1980 Mar 8-15; 56(9-10):490-7. PubMed ID: 6244676
[TBL] [Abstract][Full Text] [Related]
9. [Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases].
Lombardini R; Ciuffetti G; Paltriccia R; Scarponi AM; Savastano V; Palazzetti D; Mercuri M; Parnetti L
Ric Clin Lab; 1989; 19 Suppl 1():117-9. PubMed ID: 2629069
[No Abstract] [Full Text] [Related]
10. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
[TBL] [Abstract][Full Text] [Related]
11. [The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
Paterna S; Martino S; Ingurgio NC; Arrostuto A; Correo S; Licata G
Clin Ter; 1994 Apr; 144(4):307-19. PubMed ID: 7911406
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
[No Abstract] [Full Text] [Related]
13. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
[No Abstract] [Full Text] [Related]
14. [Study of carotid flow and cerebral circulatory impedance using Doppler computerized spectral analysis. Evaluation of the effect of buflomedil].
Scondotto G; De Fabritiis A; Caniato A; Pili C; Borgatti E
Minerva Cardioangiol; 1986 Nov; 34(11):751-8. PubMed ID: 3543731
[No Abstract] [Full Text] [Related]
15. [Use of buflomedil hydrochloride in ocular pathology].
Campinchi R; Schmitt A
Bull Soc Ophtalmol Fr; 1981; 81(4-5):413-4. PubMed ID: 7261227
[No Abstract] [Full Text] [Related]
16. [The use of buflomedil in the treatment of post-traumatic cerebral edema].
Urciuoli R; Reggio S
Agressologie; 1988 May; 29(6):469-71. PubMed ID: 3213896
[No Abstract] [Full Text] [Related]
17. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
[No Abstract] [Full Text] [Related]
18. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
Marci M; Albiani B; Ricci M; Russo F
Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
Savagnone E; Sunseri V
Minerva Cardioangiol; 1985 Nov; 33(11):757-64. PubMed ID: 4088478
[No Abstract] [Full Text] [Related]
20. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
Clissold SP; Lynch S; Sorkin EM
Drugs; 1987 May; 33(5):430-60. PubMed ID: 3297620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
